Phase 1 Dose Escalation and PK Study of Cu(II)ATSM in ALS/MND
Clinical trial NCT02870634 · COMPLETED
Trial details
- NCT number
- NCT02870634
- Sponsor
- Collaborative Medicinal Development Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-16
- Primary completion
- 2019-10-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.